HighMark Wealth Management’s Idexx Laboratories IDXX Stock Holding History

HighMark Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$105K	Hold	199	–	–	0.04%	121
2026 Q1	$112K	Hold	199	–	–	0.05%	106
2025 Q4	$135K	Buy	199 +7	+4%	+$4.77K	0.05%	97
2025 Q3	$123K	Hold	192	–	–	0.05%	103
2025 Q2	$103K	Hold	192	–	–	0.05%	114
2025 Q1	$80.6K	Hold	192	–	–	0.05%	101
2024 Q4	$79.4K	Hold	192	–	–	0.05%	98
2024 Q3	$97K	Hold	192	–	–	0.05%	106
2024 Q2	$93.5K	Hold	192	–	–	0.06%	102
2024 Q1	$104K	Hold	192	–	–	0.06%	96
2023 Q4	$107K	Hold	192	–	–	0.08%	90
2023 Q3	$84K	Hold	192	–	–	0.07%	90
2023 Q2	$96.4K	Hold	192	–	–	0.07%	85
2023 Q1	$96K	Buy	+192	New	+$91.9K	0.07%	99
2021 Q3	–	Sell	-10	Closed	-$6K	–	512
2021 Q2	$6K	Sell	10 -5	-33%	-$2.76K	﹤0.01%	331
2021 Q1	$7K	Sell	15 -21	-58%	-$10.5K	0.01%	297
2020 Q4	$18K	Sell	36 -1	-3%	-$447	0.02%	170
2020 Q3	$15K	Sell	37 -24	-39%	-$8.87K	0.01%	187
2020 Q2	$20K	Buy	61 +25	+69%	+$7.24K	0.02%	133
2020 Q1	$8K	Buy	+36	New	+$9.39K	0.01%	167

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

HighMark Wealth Management's IDXX Position: Q2 2026 in Review

HighMark Wealth Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 199 shares worth $105K. The position accounts for 0.04% of the portfolio, ranked #121.

HighMark Wealth Management first reported a position in IDXX in Q1 2020 and has held it in 20 quarters since. The position peaked at $135K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

HighMark Wealth Management held 199 shares of Idexx Laboratories worth $105K as of Q2 2026.
HighMark Wealth Management left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.04% of HighMark Wealth Management's portfolio in Q2 2026, its #121 holding.
HighMark Wealth Management first reported a position in Idexx Laboratories in Q1 2020 and has held it in 20 quarters since.
HighMark Wealth Management's Idexx Laboratories position peaked at $135K in Q4 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.